Title:
治療効率の増強のために鼻腔内送達する中和抗体に基づく組成物および方法
Document Type and Number:
Japanese Patent JP6595448
Kind Code:
B2
Abstract:
The present invention provides methods for treatment or prophylaxis of viruses, particularly influenza virus, by administration of agents, particularly neutralizing antibodies or active fragments thereof, directly to the respiratory tract, including by intranasal or inhalation administration. The invention provides compositions suitable for intranasal or inhalation treatment and administration. The invention includes methods for treatment or prophylaxis combining intranasal or inhalation administration with intraperitoneal or intravenous administration of antibodies.
Inventors:
Wittkind, Michael
Vigil, Adam
Vigil, Adam
Application Number:
JP2016502667A
Publication Date:
October 23, 2019
Filing Date:
March 14, 2014
Export Citation:
Assignee:
Confect Corporation
International Classes:
A61K39/395; A61P31/16
Domestic Patent References:
| JP62175426A | ||||
| JP2010521147A | ||||
| JP2011506344A |
Foreign References:
| US20080299151 | ||||
| WO2013007770A1 |
Other References:
Clin. Microbiol. Reviews, 1999, Vol.12, No.3, pp.383-393
Clinical and Vaccine Immunology, 2010, Vol.17, No.9, pp.1363-1370
Clinical and Vaccine Immunology, 2010, Vol.17, No.9, pp.1363-1370
Attorney, Agent or Firm:
Tomoko Nakatani